Chronic kidney disease and reduced renal COX2 expression in xanthinuria: a case-control study

Marie-Hélène Normand, François Gougeon, Naeem Bhojani, Mélanie Dieudé, Guillaume Bollée · 2026

Read Chronic kidney disease and reduced renal COX2 expression in xanthinuria: a case-control study by Marie-Hélène Normand, François Gougeon, Naeem Bhojani, Mélanie Dieudé, Guillaume Bollée (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13591799.txt.

Description

Marie-Hélène Normand and four colleagues report, in 2026, the first kidney biopsy ever described in xanthinuria, a rare inherited disorder. A fault in one enzyme floods urine with xanthine, which can form stones. Their patient, a 38 year old Afghan man, had a large staghorn stone removed. Gene tests confirmed the enzyme fault. Yet his kidney function kept sliding afterward, with protein leaking into urine.

A biopsy of the other kidney showed advanced scarring with no crystal deposits at all. One enzyme tied to protective prostaglandin making, COX2, was sharply reduced in his tubules versus comparison tissue. He reached kidney failure at 41 and did well after a transplant. Normand and the team propose COX2 loss as a new lead on how this disease harms kidneys.

Catalog record

CREATORMarie-Hélène Normand, François Gougeon, Naeem Bhojani, Mélanie Dieudé, Guillaume Bollée
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE16826
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13591799

Browse the full library · About the Tower of Babel